THE JOHN CHARNLEY AWARD: Prevention of Readmission for Venous Thromboembolic Disease after Total Hip Arthroplasty

Abstract

Therapeutic study, Level I-1 (high-quality randomized trial with statistically significant difference or no statistically significant difference but narrow confidence intervals). See the Guidelines for Authors for a complete description of levels of evidence.